June 4th 2020
Tannaz Armaghany, MD, discusses the utility of circulating tumor DNA in colorectal cancer.
April 4th 2020
Tannaz Armaghany, MD, discusses sorafenib versus lenvatinib as first-line therapy for patients with hepatocellular carcinoma.
March 26th 2020
Tannaz Armaghany, MD, discusses the importance of NCI-MATCH trial in colorectal cancer.
March 13th 2020
Tannaz Armaghany, MD, discusses up-front gene sequencing in patients with colorectal cancer.